Literature DB >> 6177800

Epidermal growth factor receptor in human epidermal cells: direct demonstration in cultured cells.

E O'Keefe, T Battin, R Payne.   

Abstract

The interaction of [125I] labeled murine epidermal growth factor (EGF)( with cultured human keratinocytes has been studied. Epidermal cells from neonatal foreskins were propagated to confluence in 24-well culture trays and incubated with [125I] EGF for binding assays. Association reached equilibrium within 2-4 hr at 4 degrees and slightly earlier at 37 degrees. EGF bound at 37 degrees dissociates very slowly from cells, since it can be shown to enter cells and is degraded to trichloracetic-acid-soluble material. Cells exposed to chloroquine, an inhibitor of lysosomal enzymes, fail to degrade internalized [125I] EGF. Scatchard plots of the binding data yield a dissociation constant of 1 X 10(-9) m and show that epidermal cells bind approximately 3-4 X 10(4) molecules of EGF. Cells exposed to EGF alter their ability to bind EGF by decreasing the number of binding sites in a time- and concentration-dependent manner. Differentiation of epidermal cells in culture poses a problem in assessment of binding of EGF and possibly of other biologically active ligands, since cells lose the ability to bind EGF as they differentiate. These findings indicate that isolated epidermal cells possess a functional receptor for EGF which binds and responds to EGF in a manner similar to that described for other cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6177800     DOI: 10.1111/1523-1747.ep12510246

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  16 in total

1.  Regulation of epidermal growth factor receptor expression in normal and transformed keratinocytes.

Authors:  M F te Pas; P M van Bergen en Henegouwen; J Boonstra; M Ponec
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

2.  Safety Profile and Clinical Recommendations for the Use of Lapatinib.

Authors:  Dimitrios Chatsiproios
Journal:  Breast Care (Basel)       Date:  2010-04-26       Impact factor: 2.860

3.  Epidermal growth factor (EGF)-induced morphological changes in the basement membrane of chick embryonic skin. An electron-microscopic study.

Authors:  Y Akimoto; A Obinata; H Endo; H Hirano
Journal:  Cell Tissue Res       Date:  1988       Impact factor: 5.249

4.  EGF receptor expression and growth of psoriatic and normal human keratinocytes are modulated by 1.25 (OH)2-vitamin D3 ex vivo.

Authors:  A M Boisseau-Garsaud; P Donatien; C Margerin; A Taïeb
Journal:  Arch Dermatol Res       Date:  1996-07       Impact factor: 3.017

5.  Actions of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on human epidermal keratinocytes in culture.

Authors:  W F Greenlee; K M Dold; R Osborne
Journal:  In Vitro Cell Dev Biol       Date:  1985-09

6.  Epidermal growth factor receptors in idiopathic and virally induced skin diseases.

Authors:  L B Nanney; D L Ellis; J Levine; L E King
Journal:  Am J Pathol       Date:  1992-04       Impact factor: 4.307

7.  The effect of choleragen and epidermal growth factor on proliferation and maturation in vitro of human ectocervical cells.

Authors:  M A Stanley; K Dahlenburg
Journal:  In Vitro       Date:  1984-02

8.  Role of EGF receptor ligands in TCDD-induced EGFR down-regulation and cellular proliferation.

Authors:  Christina M Campion; Sandra Leon Carrion; Gayatri Mamidanna; Carrie Hayes Sutter; Thomas R Sutter; Judith A Cole
Journal:  Chem Biol Interact       Date:  2016-04-23       Impact factor: 5.192

9.  Functionalized silk biomaterials for wound healing.

Authors:  Eun Seok Gil; Bruce Panilaitis; Evangelia Bellas; David L Kaplan
Journal:  Adv Healthc Mater       Date:  2012-11-02       Impact factor: 9.933

10.  Biofunctionalized electrospun silk mats as a topical bioactive dressing for accelerated wound healing.

Authors:  A Schneider; X Y Wang; D L Kaplan; J A Garlick; C Egles
Journal:  Acta Biomater       Date:  2008-12-31       Impact factor: 8.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.